LB Pharmaceuticals Inc (LBRX) vs Replimune Group, Inc. (REPL)
LB Pharmaceuticals Inc and Replimune Group, Inc. are both Biotechnology companies. LB Pharmaceuticals Inc and Replimune Group, Inc. are of similar size ($1.2B and $1.2B). Across the 10 metrics below, LB Pharmaceuticals Inc leads on 8 and Replimune Group, Inc. on 2.
Valuation
Profitability
| Metric | LBRX | REPL | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (72.07%) | (134.29%) | (57.72%) |
| Return on assets | (47.38%) | (82.28%) | (49.22%) |
| Return on invested capital | (1,304.79%) | (1,154.69%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack